NDC codes

404917 NDC codes with hospital pricing data in the network.

• NDC 00143-9729-01 — Benztropine mesylate injection 1 mg/mLAI (440 hospitals, 172–334 samples)
• NDC 00173-0892-42 — Nucala 100 mg/mL injection in prefilled syringeAI (358 hospitals, 136–334 samples)
• NDC 63323-0605-04 — Enoxaparin injection 100 mg per mLAI (95 hospitals, 244–334 samples)
• NDC 43598-0172-15 — Phenylephrine injection 100 mcg/mL, 5 mL vialAI (96 hospitals, 208–334 samples)
• NDC 47426-0401-10 — Aprepitant intravenous injection for nauseaAI (99 hospitals, 244–334 samples)
• NDC 00143-9092-01 — Doxorubicin hydrochloride 10 mg injection vialAI (78 hospitals, 307–334 samples)
• NDC 60505-6279-00 — Cisplatin intravenous solutionAI (32 hospitals, 325–334 samples)
• NDC 71288040202A — HEPARIN (6 hospitals, 217–334 samples)
• NDC 67457042312D — DEXAMETHASONE 4MG/ML VIAL (1 hospital, 244–334 samples)
• NDC 70069002125D — DEXAMETHASONE 10MG/ML VIAL (1 hospital, 244–334 samples)
• NDC 42494-0419-05 — Methylene blue 1% intravenous solutionAI (103 hospitals, 261–333 samples)
• NDC 60687-0129-11 — Docusate sodium 100 mg capsuleAI (338 hospitals, 252–333 samples)
• NDC 409114402 — Verapamil 2.5 mg/mL injection, 4 mL vialAI (96 hospitals, 189–333 samples)
• NDC 00527-4107-37 — Mexiletine 150 mg oral capsuleAI (158 hospitals, 252–333 samples)
• NDC 338001718 — Dextrose 5% in water IV solutionAI (83 hospitals, 107–332 samples)
• NDC 54288-0111-05 — Hyoscyamine sulfate injectionAI (271 hospitals, 224–332 samples)
• NDC 55390-0101-10 — Terbutaline injection 1 mg per mLAI (119 hospitals, 44–332 samples)
• NDC 64380-0159-01 — Megestrol acetate 40 mg tabletsAI (343 hospitals, 188–332 samples)
• NDC 00069-6001-21 — Cerebyx (fosphenytoin) 500 mg injection vialAI (582 hospitals, 188–332 samples)
• NDC 338001711 — Dextrose 5% in water IV solutionAI (71 hospitals, 107–332 samples)
• NDC 00409-1465-01 — Nalbuphine 20 mg/mL injectionAI (310 hospitals, 242–332 samples)
• NDC 61703-0408-25 — Methotrexate injection, 1 gram per 40 mL vialAI (126 hospitals, 44–332 samples)
• NDC 00143-9710-01 — Milrinone intravenous solutionAI (191 hospitals, 305–332 samples)
• NDC 00409-1626-21 — Butorphanol 2 mg/mL injectionAI (325 hospitals, 44–332 samples)
• NDC 00641-6136-01 — Fosphenytoin 100 mg injectionAI (337 hospitals, 188–332 samples)
• NDC 00005-0100-01 — Meningococcal group B vaccine (Trumenba), 0.5 mL doseAI (106 hospitals, 179–332 samples)
• NDC 45802-0650-78 — loratadine 10 mg tabletAI (192 hospitals, 188–332 samples)
• NDC 00338-7036-01 — Amino acid, dextrose and electrolyte IV solutionAI (129 hospitals, 43–331 samples)
• NDC 904198861 — Acetaminophen 500 mg tabletAI (46 hospitals, 187–331 samples)
• NDC 904672059 — ACETAMINOPHEN 500 MG TABLETAI (60 hospitals, 187–331 samples)
• NDC 00143-9857-25a — INJECTION, CEFTRIAXONE SODIUM, PER 250 MG (1 hospital, 259–331 samples)
• NDC 43598-0262-23 — Fulvestrant 250 mg/5 mL intramuscular injection syringeAI (309 hospitals, 205–331 samples)
• NDC 50580-0412-02 — Acetaminophen 500 mg tabletsAI (131 hospitals, 187–331 samples)
• NDC 00641-6177-01 — Octreotide acetate injection, 200 mcg per mLAI (125 hospitals, 43–331 samples)
• NDC 00338-7032-01 — Clinimix E with dextrose intravenous solutionAI (216 hospitals, 43–331 samples)
• NDC 63323-0090-20 — Sodium chloride injection solutionAI (82 hospitals, 43–331 samples)
• NDC 409733720 — Ceftriaxone sodium 250 mg injectionAI (18 hospitals, 286–331 samples)
• NDC 00338-9647-12 — Vasopressin 40 units in 100 mL saline premixAI (81 hospitals, 43–331 samples)
• NDC 00409-3301-01 — Dexmedetomidine injection, 4 mcg/mL, 20 mL vialAI (35 hospitals, 43–331 samples)
• NDC 00409-3301-10 — Dexmedetomidine injection 4 mcg/mL, 20 mL vialAI (42 hospitals, 43–331 samples)
• NDC 70710-1937-07 — Verapamil 5 mg/2 mL single-dose vial injectionAI (27 hospitals, 214–331 samples)
• NDC 00003-2188-51 — Abatacept injection, 10 mgAI (18 hospitals, 268–331 samples)
• NDC 11111-0020-58 — VASOPRESSIN IN NS 0.4 UNIT/ML IV SOLN (OR USE) ADE (4 hospitals, 43–331 samples)
• NDC 00268-1111-10 — COCKLEBUR 1:20 SC SOLN (4 hospitals, 43–331 samples)
• NDC 11111-0020-88 — KETAMINE HCL 50 MG/ML IV SOSY (4 hospitals, 43–331 samples)
• NDC 00078-1168-61 — Cosentyx 125 mg IV infusion medicationAI (482 hospitals, 123–330 samples)
• NDC 12496-1204-03 — Buprenorphine-naloxone sublingual film, 4 mg/1 mgAI (159 hospitals, 33–330 samples)
• NDC 00641-6174-10 — Octreotide acetate injection, 50 mcg/mLAI (554 hospitals, 33–330 samples)
• NDC 00703-3311-04 — Octreotide acetate 100 mcg/mL injectionAI (213 hospitals, 33–330 samples)
• NDC 62756-0348-44 — Octreotide injection 50 mcg per mLAI (108 hospitals, 33–330 samples)